These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27506804)

  • 21. Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma.
    Apisarnthanarax S; Bowen SR; Combs SE
    Semin Radiat Oncol; 2018 Oct; 28(4):309-320. PubMed ID: 30309641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What Conditions Make Proton Beam Therapy Financially Viable in Western Canada?
    Smith WL; Smith CD; Patel S; Eisenstat DD; Quirk S; Mackenzie M; Olivotto IA
    Cureus; 2018 Nov; 10(11):e3644. PubMed ID: 30723643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience.
    Ono T; Hareyama M; Nakamura T; Kimura K; Hayashi Y; Azami Y; Hirose K; Hatayama Y; Suzuki M; Wada H; Kikuchi Y; Nemoto K
    Radiat Oncol; 2016 Apr; 11():56. PubMed ID: 27090216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of meningioma and glioma with protons and carbon ions.
    Adeberg S; Harrabi SB; Verma V; Bernhardt D; Grau N; Debus J; Rieken S
    Radiat Oncol; 2017 Dec; 12(1):193. PubMed ID: 29195506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton therapy for thoracic malignancies: a review of oncologic outcomes.
    Patel NV; Yu NY; Koroulakis A; Diwanji T; Sawant A; Sio TT; Mohindra P
    Expert Rev Anticancer Ther; 2021 Feb; 21(2):177-191. PubMed ID: 33118427
    [No Abstract]   [Full Text] [Related]  

  • 26. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton beam therapy for the treatment of esophageal cancer.
    Lin SH; Hallemeier CL; Chuong M
    Chin Clin Oncol; 2016 Aug; 5(4):53. PubMed ID: 27558254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial.
    Galland-Girodet S; Pashtan I; MacDonald SM; Ancukiewicz M; Hirsch AE; Kachnic LA; Specht M; Gadd M; Smith BL; Powell SN; Recht A; Taghian AG
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):493-500. PubMed ID: 24880212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Outcomes and Toxicity of Proton Radiotherapy for Breast Cancer.
    Verma V; Shah C; Mehta MP
    Clin Breast Cancer; 2016 Jun; 16(3):145-54. PubMed ID: 26995159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doing poorly by doing good: the bottom line of proton therapy for children.
    Johnstone PA; Kerstiens J
    J Am Coll Radiol; 2014 Oct; 11(10):995-7. PubMed ID: 24881504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Proton beam therapy at Shizuoka Cancer Center].
    Murayama S; Fuji H
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1806-12. PubMed ID: 19920382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent chemoradiotherapy using proton beams can reduce cardiopulmonary morbidity in esophageal cancer patients: a systematic review.
    Nonaka T; Kawashiro S; Ishikawa H; Ito Y; Nemoto K; Ishihara R; Oyama T; Oyama T; Kato K; Kato H; Kawakubo H; Kawachi H; Kuribayashi S; Kono K; Kojima T; Takeuchi H; Tsushima T; Toh Y; Booka E; Makino T; Matsuda S; Matsubara H; Mano M; Minashi K; Miyazaki T; Muto M; Yamaji T; Yamatsuji T; Yoshida M; Kitagawa Y;
    Esophagus; 2023 Oct; 20(4):605-616. PubMed ID: 37328706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary neutron doses in a compact proton therapy system.
    Stichelbaut F; Closset M; Jongen Y
    Radiat Prot Dosimetry; 2014 Oct; 161(1-4):368-72. PubMed ID: 24591728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of fractionated targeted proton beam therapy in the treatment of primary optic nerve sheath meningioma].
    Moyal L; Vignal-Clermont C; Boissonnet H; Alapetite C
    J Fr Ophtalmol; 2014 Apr; 37(4):288-95. PubMed ID: 24629446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to Date.
    Huang D; Frank SJ; Verma V; Thaker NG; Brooks ED; Palmer MB; Harrison RF; Deshmukh AA; Ning MS
    Int J Part Ther; 2021; 8(1):339-353. PubMed ID: 34285960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton beam therapy for a patient with large rhabdomyosarcoma of the body trunk.
    Takizawa D; Oshiro Y; Mizumoto M; Fukushima H; Fukushima T; Sakurai H
    Ital J Pediatr; 2015 Nov; 41():90. PubMed ID: 26573272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Scanning Beam for Superficial Dose in Proton Therapy.
    Moskvin VP; Estabrook NC; Cheng CW; Das IJ; Johnstone PA
    Technol Cancer Res Treat; 2015 Oct; 14(5):643-52. PubMed ID: 24945369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton therapy of cancer: potential clinical advantages and cost-effectiveness.
    Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
    Acta Oncol; 2005; 44(8):850-61. PubMed ID: 16332592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Radiobiological Effects of Proton Beam Therapy: Impact on DNA Damage and Repair.
    Vitti ET; Parsons JL
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31284432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immobilization considerations for proton radiation therapy.
    Wroe AJ; Bush DA; Slater JD
    Technol Cancer Res Treat; 2014 Jun; 13(3):217-26. PubMed ID: 24066953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.